2.5000
24-二月-25 16:45:00
15 分钟延时
股票
-0.0500
-1.96%
今日范围
2.4900 - 2.6200
ISIN
N/A
来源
NASDAQ
Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease
08 2月 2021 08:30:00 条件 Nasdaq GlobeNewswire
Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study
02 2月 2021 08:30:00 条件 Nasdaq GlobeNewswire
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 1月 2021 08:30:00 条件 Nasdaq GlobeNewswire